You are here: Home > Institute of Excellence (CPD) > Calendar > CPD Events > Therapeutics Refresher Weekend

Therapeutics Refresher Weekend 

Date: 18/05/2019 - 19/05/2019

Venue: ACO, 374 Cardigan Street, Carlton, VIC, 3053

Provider: Australian College of Optometry

Contact: Liz Salvatore, [E] cpd@aco.org.au, [P] 03 9349 7477

Learning Objectives

  • Classify allergic eye disease and be aware of the diagnostic signs that are associated with each category
  • Recognise the clinical features of allergic eye disease and discuss the criteria for referral
  • Causes of corneal ulceration
  • List the risk factors, causes, clinical features, differential diagnostic signs that are characteristic of microbial keratitis (MK), laboratory investigations that help a clinician identify the pathogen and the treatment of the condition
  • Demonstrate an understanding of the challenges of antibiotic sensitivity and resistance
  • Discuss the role of steroids in the management of MK
  • Understand the causes, pathogenesis and distinguishing clinical features of episcleritis, scleritis as well as systemic diseases that are associated with the conditions
  • Explain the medical treatment of episcleritis and scleritis
  • List some laboratory investigations that are useful in the diagnosis of episcleritis and scleritis
  • Discuss the importance of acute anterior uveitis (AAU) and its association with HLA-B27 status and list some systemic conditions that are classified as HLA-B27 associated AAU entities
  • Describe the clinical features of herpes simplex viral keratouveitis, herpes zoster ophthalmicus (HZO), Fuchs hetereochromic uveitis, Possner-Schlossman syndrome and uveitis-glaucoma-hyphaema syndrome
  • Explain the medical management of acute and chronic anterior uveitis
  • Understand the causes and clinical features of intermediate uveitisv
  • Understand the possible causes of posterior uveitis
  • Be familiar with the treatment options for intermediate uveitis and posterior uveitis
  • List some useful laboratory investigations that assist in the diagnosis of intermediate uveitis
  • Explain the treatment regimen for intermediate and posterior uveitis
  • Demonstrate an awareness of primary ocular causes, secondary ocular causes and systemic causes of retinal vasculitis
  • Contrast the clinical features of the various ‘white dot’ syndromes.
  • Identify the morphological and functional features of optic neuropathies
  • Recognise the differences between papilloedema and disc swelling
  • Understand the clinical manifestations of a variety of inflammatory optic neuropathies
  • Explain the relationship between optic neuritis and multiple sclerosis (MS)
  • Describe the clinical signs that enable one to distinguish between true disc swelling and ‘pseudo’ disc swelling
  • Demonstrate an awareness of the difference between unilateral versus bilateral causes of disc swelling
  • List the causes of inflammatory optic neuropathy and the differential diagnosis of the condition
  • Demonstrate an understanding of the management of optic neuritis
  • List the features of temporal arteritis and recognise the need for urgent referral of the condition.
  • Explain the relevance of intraocular hypertension in the overall diagnosis and management of glaucoma, with particular reference to relevant clinical trials
  • Use the common glaucoma risk calculators to help plan a course of management for a patient
  • List the roles that spectral domain OCT (SD-OCT) plays in the management of glaucoma
  • Discuss the benefits of SD-OCT in monitoring the progression of glaucoma
  • Understand the definition, epidemiology and pathophysiology of angle closure
  • Identify the various stages of angle closure according to the International Society of Geographical and Epidemiologic Ophthalmology (ISGEO) classification of the condition
  • Define normal tension glaucoma (NTG) and understand the causes of and the conditions that masquerade as NTG
  • Explain the detailed examination and investigations that are warranted before a diagnosis of NTG can be made
  • Explain the approaches to treatment of NTG
  • Describe the approaches that are taken to reduce intraocular pressure (IOP)
  • Explain the indications for a particular mode of treatment as well as the appropriate choice of drug
  • Demonstrate an understanding of the essential role of selective laser trabeculoplasty (SLT) in the management of glaucoma
  • 7. List some new and interesting approaches to the treatment of glaucoma, including: - iStent in conjunction with cataract surgery - New potential therapeutic targets for medication - Neuroprotective agents - Lifestyle modifications for glaucoma patients - XEN Gel Stent

Max points awarded: 27.00

Session Information

Name
Allergic Eye Disease, Infective Conjunctivitis and Microbial Keratitis
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
4.50
Name
Episcleritis, Scleritis and Anterior uveitis
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
4.50
Name
Intermediate uveitis and posterior uveitis
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
4.50
Name
Optic Neuropathy
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
4.50
Name
Glaucoma
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
4.50
Name
Glaucoma
Activity Type
Face to Face with Assessment
Therapeutic?
Yes
Manufacturer/Supplier?
No
Points for attending & Passing Assessment
4.50

NameActivity TypeTherapeutic?Manufacturer/
Supplier?
Points for attending &
Passing Assessment
Allergic Eye Disease, Infective Conjunctivitis and Microbial KeratitisFace to Face with AssessmentYesNo4.50
Episcleritis, Scleritis and Anterior uveitisFace to Face with AssessmentYesNo4.50
Intermediate uveitis and posterior uveitisFace to Face with AssessmentYesNo4.50
Optic NeuropathyFace to Face with AssessmentYesNo4.50
GlaucomaFace to Face with AssessmentYesNo4.50
GlaucomaFace to Face with AssessmentYesNo4.50